Quintus Fabius Maximus, the Roman dictator whose ex post facto victory over the original Hannibal has for centuries inspired both admiration and contempt, would applaud the strategies of the major players in the Ontario nuclear reactor competition. The major players…
Category: Isotope reactor
Areva still eyes Ontario, mulls involvement in “NRU II” as CNSC approves new CANDU design
Areva is still in the Ontario reactor competition, and remains open to playing a role in the future of Canadian nuclear research, a company executive said in a conference call on September 18. This follows the Canadian Nuclear Safety Commission’s…
Ontario–federal nuclear negotiation continues, as does CANDU-climate disconnect
Last month the Canadian federal government announced it was going to privatize Atomic Energy Canada Limited (AECL). The medical isotope part of the business would be separated from power reactors. The feds hoped that this would thereby ease Ontario’s troubled…
AECL purchase decision depends on Ontario outcome, Areva executive hints
Would Areva, the French nuclear company, buy the power reactor part of Atomic Energy Canada Limited if AECL wins the Ontario reactor competition? I put this question to Jacques Besnainou, president of Areva North America, in a conference call yesterday. The…
Nuclear renaissance in U.S. at the crossroads: industry elbows are too low
Everybody is wondering where U.S. nuclear policy is going under the current administration and congress. Early indications are not encouraging: the stimulus bill signed last week excluded nuclear power from a package that aims to spur development of low-carbon energy.…